Moderna to Request FDA EUA for COVID-19 Vaccine for Young Children
This week, Moderna announced it plans over the coming weeks to submit an emergency use authorization (EUA) request to the U.S. Food and Drug Administration (FDA) for a two-dose COVID-19 mRNA vaccine for children six months to six years old. The vaccine for children is a quarter of the dose of Moderna’s adult COVID-19 vaccine…
Read More »